Merck's new injectable cancer drug, Keytruda Qlex, promises to transform patient treatment with a quick administration time and flexible dosing, all while maintaining effectiveness. Available in late September, this shift is critical as the market braces for biosimilar competition.
A recent study reveals that high sucralose intake may hinder immunotherapy effectiveness in cancer patients. Discover how arginine supplements could be the key to improving outcomes.
A groundbreaking study reveals that a new mRNA vaccine can activate the immune system and significantly shrink tumors in mice, sparking hope for a universal cancer vaccine that could revolutionize treatment methods.
A groundbreaking study from the University of Florida reveals that a new mRNA vaccine could trigger a powerful immune response against various cancers, offering hope for treatment-resistant tumors. Researchers found that this approach might lead to a universal cancer vaccine that could complement existing therapies.